Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance

Pediatric Hematology and Oncology

Volumn 29, Issue 6, 2012, Pages 551-561

  Karakurt, Hasan ^a   Sarper, Nazan ^a   Kiliç, Suar Çaki ^a   Gelen, Sema Aylan ^a   Zengin, Emine ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

ALL; Insulin resistance; Late effects; Metabolic syndrome; Obesity

Indexed keywords

ANTINEOPLASTIC AGENT; GLUCOSE; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; SOMATOMEDIN C;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVOR; CARDIOVASCULAR RISK; CHILD; CHILDHOOD OBESITY; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; SCHOOL CHILD; SIBLING; THYROID FUNCTION TEST;

ADOLESCENT; ADULT; BODY COMPOSITION; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NEOPLASM RECURRENCE, LOCAL; OBESITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 84865336891     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2012.708892     Document Type: Article

References (32)

1. Möricke A, ZimmermannM, Reiter A, et al. Long-termresults of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFMstudy group from1981 to 2000. Leukemia. 2010;24:265-284.
2. Aldhafiri F, Al-Nasser A, Al-Sugair A, et al. Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia. Pediatr Blood Cancer. 2012;59:133-137.
3. Veringa SJ, van Dulmen-den Broeder E, Kaspers GJ, Veening MA. Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;58:278-282.
4. Tonorezos ES, Vega GL, Sklar CA, et al. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia. Pediatr Blood Cancer. 2012;58:31-36.
5. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. Blood. 2008;111: 5515-5523.
6. Hatipoglu N, Ozturk A, Mazicioglu MM, et al. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr. 2008;167:383-389. (Pubitemid 351322464)
7. Neyzi O Günöz H Furman A et al Türk cocuklarinda vücut aǧirliǧi, boy uzunluǧu, bas? c?evresi ve vücut kitle indeksi referans deǧerleri. [Reference ranges for body weight, height, head circumference and bodymass index in Turkish children]. Cocuk Saǧliǧi ve Hastaliklari Dergisi. 2008;51:1-14. (Pubitemid 351310543)
8. Robert JK, Cynthia LO, Shumei SG, et al. 2000 CDC Growth Charts for the United States: Methods andDevelopment.DHHSPublicationNo. (PHS) 2002-1696, Series 11,No. 246.Hyattsville,Maryland. http://www.cdc.gov/nchs charts.
9. Zimmet P, Alberti KG, Kaufman F, et al. Consensus group the metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes. 2007;8:299-306. (Pubitemid 47422902)
10. Keskin M, Kurtoǧlu S, Kendirci M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500-e503.
11. Madeira IR, Carvalho CN, Gazolla FM, et al. Cut-off point for homeostatic model assessment for insulin resistance (HOMA-IR) index established from receiver operating characteristic (ROC) curve in the detection of metabolic syndrome in overweight pre-pubertal children. Arq Bras Endocrinol Metabol. 2008;52:1466-1473.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl. 1):562-569. [Erratum in: Diabetes Care. 2010;33(4):e57].
13. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004;89: 2526-2539. (Pubitemid 38766328)
14. Bereket A, Turan S, Omar A, et al. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty. Horm Res. 2006;65:96-105. (Pubitemid 43289475)
15. Cizmecioǧlu FM, Etiler N, Hamzaoǧlu O, Hatun S. Prevalence of metabolic syndrome in schoolchildren and adolescents in Turkey: a population based study. J Pediatr Endocrinol Metab. 2009;22: 703-714.
16. Zee P, Chen CH. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1986;8:294-299. (Pubitemid 17229761)
17. Rogers PC, Meacham LR, Oeffinger KC, et al. Obesity in pediatric oncology. Pediatr Blood Cancer. 2005;45:881-891 [review]. (Pubitemid 41552155)
18. Asner S, Ammann RA, Ozsahin H, et al. Obesity in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51:118-122. (Pubitemid 351717401)
19. OeffingerKC,MertensAC, SklarCA, et al.Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report fromthe childhood cancer survivor study. J Clin Oncol. 2003;21:1359-1365. (Pubitemid 46606416)
20. Gofman I, Ducore J. Risk factors for the development of obesity in children surviving ALL and NHL. J Pediatr Hematol Oncol. 2009;31:101-107.
21. Trimis G, Moschovi M, Papassotiriou I, et al. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol. 2007;29:309-314. (Pubitemid 46707511)
22. Razzouk BI, Rose SR, Hongeng S, et al. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2007;25:1183-1189. (Pubitemid 46646518)
23. Kourti M, Tragiannidis A, Makedou A, et al. Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol. 2005;27:499-501. (Pubitemid 41395905)
24. Kitis Y, Bilgili N, Hisar F, Ayaz S. Frequency and affecting factors of metabolic syndrome in women older than 20 years of age. Anadolu Kardiyol Derg. 2010;10:111-119, doi:10.5152/akd.2010.033 [article in Turkish].
25. Delibasi T, Karaaslan Y, Ustun I, et al. National prevalence of underweight, overweight and obesity in Turkey: cross sectional study of a representative adult population. Cent Eur J Med. 2007;2:294-303, doi:10.2478/S11536-007-0024-4. (Pubitemid 47025069)
26. Karaman S, Ercan O, Yildiz I, et al. Late effects of childhood ALL treatment on body mass index and serumleptin levels. J Pediatr Endocrinol Metab. 2010;23:669-674.
27. Moran A, Jacobs DR, Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039-2044. (Pubitemid 29458369)
28. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107:1303-1312. (Pubitemid 44452780)
29. Franco C, Brandberg J, Lönn L, et al. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab. 2005;90:1466-1474. (Pubitemid 40464006)
30. ArgüellesB,Barrios V,Pozo J, et al.Modifications of growth velocity and the insulin-like growthfactor system in childrenwith acute lymphoblastic Leukemia: a longitudinal study. JClinEndocrinolMetab. 2000;85:4087-4092. (Pubitemid 32055357)
31. Birkebaek NH, Fisker S, Clausen N, et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998;30:351-356. (Pubitemid 28198930)
32. Järvelä LS,Kemppainen J,Niinikoski H, et al. Effects of a home-based exercise programon metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;59:155-160.